6H5N image
Deposition Date 2018-07-25
Release Date 2018-09-26
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6H5N
Keywords:
Title:
Plasmodium falciparum Pfs48/45 C-terminal domain bound to monoclonal antibody 85RF45.1
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.23 Å
R-Value Free:
0.28
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 2 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Gametocyte surface protein P45/48
Gene (Uniprot):PF45/48
Chain IDs:A, D
Chain Length:136
Number of Molecules:2
Biological Source:Plasmodium falciparum
Polymer Type:polypeptide(L)
Molecule:Antibody 85RF45.1 light chain
Chain IDs:B, E
Chain Length:212
Number of Molecules:2
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Molecule:Antibody 85RF45.1 heavy chain
Chain IDs:C, F
Chain Length:220
Number of Molecules:2
Biological Source:Rattus norvegicus
Ligand Molecules
Primary Citation
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.
Nat Commun 9 3822 3822 (2018)
PMID: 30237518 DOI: 10.1038/s41467-018-06340-9

Abstact

The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infected humans, thereby stopping the transmission cycle. One of the most promising targets for such a vaccine is the gamete surface protein, Pfs48/45. Here we establish a system for production of full-length Pfs48/45 and use this to raise a panel of monoclonal antibodies. We map the binding regions of these antibodies on Pfs48/45 and correlate the location of their epitopes with their transmission-blocking activity. Finally, we present the structure of the C-terminal domain of Pfs48/45 bound to the most potent transmission-blocking antibody, and provide key molecular information for future structure-guided immunogen design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures